Science 11
The computed 12-month bankruptcy probability of Science 11 is 0.7% (low). The 2025 annual accounts show equity of €3.16M and a net result of €-428k. Its solvency ranks better than 46% of 528 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €3.16M |
| Net result | €-428k |
| Better than sector | 46% |
| Active | 2 yrs |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 13.1% | 16.2% | |
| Net result | €-428k | €6k | |
| Equity | €3.16M | €152k | |
| Gross operating margin | €524k | €78k | |
| Total assets | €24.14M | €1.34M |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €-67k |
| Net profit | €-428k |
| Cash flow | €-68k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €24.14M |
| Equity | €3.16M |
| Debt | €20.98M |
| of which ≤ 1y | €6.98M |
| of which > 1y | €14.00M |
| Working capital | €-6.94M |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.01 |
| Quick ratio | 0.01 |
| Working capital ratio | -28.8% |
| Solvency | 13.1% |
| Debt / equity | 6.64 |
| Long-term debt ratio | 4.43 |
| Interest coverage | -52.55 |
| Gross margin | - |
| Net margin | - |
| ROA | -1.8% |
| ROE | -13.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €24.14M |
| Fixed assets | 21/28 | €24.10M |
| Tangible fixed assets | 22/27 | €24.10M |
| Current assets | 29/58 | €37k |
| Amounts receivable within one year | 40/41 | €23k |
| Cash & bank | 54/58 | €14k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €24.14M |
| Equity | 10/15 | €3.16M |
| Contributions / capital | 10/11 | €3.95M |
| Accumulated profits (losses) | 14 | €-789k |
| Amounts payable | 17/49 | €20.98M |
| Amounts payable after one year | 17 | €14.00M |
| Amounts payable within one year | 42/48 | €6.98M |
| Trade debts payable within one year | 44 | €2.41M |
| Income statement | ||
| Gross operating margin | 9900 | €524k |
| Operating result | 9901 | €-426k |
| Financial charges | 65 | €1k |
| Result before taxes | 9903 | €-428k |
| Net result for the period | 9904 | €-428k |
| Result to be appropriated | 9905 | €-428k |
| NACE primary | Real estate activities(68122) |
| Legal form | Private limited company(610) |
| Incorporation | 21-12-2023 |
| Status | Active |
| Postal code | 9000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44808H0746/00B000 | Flanders | 7,465 m² | 1 · 1,075 m² | 8.1 m · 2 fl. |
| 21803C1122/00M002 | Brussels | 1,150 m² | 1 · 1,007 m² | 28.8 m · 8 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-09-2025 Urbino BV appointed as director
- Urbino BV, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0633.503.436",
"name": "Urbino BV",
"address": "9820 Merelbeke, Hollebeekpark 20",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering besluit met eenparigheid van stemmen vanaf de datum van huidige Algemene Vergadering te benoemen als bestuurder voor een periode van onbepaalde duur: \u2022Urbino BV, met ondernemingsnummer 0633.503.436 met zetel te 9820 Merelbeke, Hollebeekpark 20 en die als vaste vertegenwoordiger voor d",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-09-29",
"filing_date": "2025-09-19",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-05-21",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1003.769.163",
"name_full": "Science 11",
"legal_form": "BV"
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}31-05-2024 Registered office moved from Brussel to Gent
- Koningsstraat 47, 1000 Brussel → 9000 Gent, Foreestelaan 86/201
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "9000 Gent, Foreestelaan 86/201",
"city": "Gent",
"region": "vlaams_gewest",
"street": "Foreestelaan",
"country": "BE",
"postcode": "9000",
"box_number": null,
"street_number": "86/201",
"locality_suffix": null
},
"old_address": {
"raw": "Koningsstraat 47, 1000 Brussel",
"city": "Brussel",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Koningsstraat",
"country": "BE",
"postcode": "1000",
"box_number": null,
"street_number": "47",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-05-31",
"filing_date": "2024-05-29",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2024-04-26",
"unanimous": true
},
"subject_company": {
"kbo": "1003.769.163",
"name_full": "CITYFORWARD SCIENCE 11",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Allen Overy Shearman Sterling (Belgium) LLP",
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Uittreksel uit de notulen van de buitengewone algemene vergadering dd. 26/04/2024.",
"Uittreksel uit de schriftelijke besluiten van de raad van bestuur dd. 26/04/2024."
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Science 11 |